Price Alert

DENTSPLY SIRONA Inc. (XRAY)

NASDAQ: XRAY · Real-Time Price · USD

13.87

0.02 (0.14%)

At close: Aug 14, 2025, 3:59 PM

13.80

-0.50%

After-hours: Aug 14, 2025, 07:33 PM EDT

0.14% (1D)

Bid	13.69
Market Cap	2.77B
Revenue (ttm)	3.67B
Net Income (ttm)	-949M
EPS (ttm)	-4.68
PE Ratio (ttm)	-2.96
Forward PE	6.33
Analyst	Hold

Ask	14
Volume	3,762,845
Avg. Volume (20D)	2,978,656
Open	13.57
Previous Close	13.85
Day's Range	13.38 - 13.88
52-Week Range	12.16 - 27.48
Beta	0.95

About XRAY

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XRAY

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XRAY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

DENTSPLY SIRONA has released their quartely earnings on Aug 7, 2025:

Revenue of $936M exceeds estimates by $2.92M, with -4.88% YoY decline.

EPS of 0.52 exceeds estimates by 0.02, with 6.12% YoY growth.

Next Earnings Release

DENTSPLY SIRONA Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-3.29%

XRAY stock has given up its prior gain. Dentsply S... Unlock content with Pro Subscription

1 week ago

-3.29%

Dentsply Sirona shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

News

4 days ago · zacks.com

International Markets and Dentsply (XRAY): A Deep Dive for Investors

Explore Dentsply's (XRAY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

6 days ago · zacks.com

Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 week ago · seekingalpha.com

DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Direc...

1 week ago · zacks.com

XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up

DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.

1 week ago · zacks.com

Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate...

1 week ago · zacks.com

Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.49 per share a year ago.

1 week ago · zacks.com

XRAY or MMSI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two stocks presents investo...

1 week ago · zacks.com

Should Value Investors Buy Dentsply Sirona (XRAY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 week ago · zacks.com

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.

2 weeks ago · zacks.com

Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Load More News